Partnering Made Easy - The Deal Making Event for Life Science Ground Breakers October 10-October 12, 2018 - The Ritz-Carlton, Laguna Niguel, CA https://bionetwork.wbresearch.com/ Immunomic will be attending for the 3rd year ...
Immunomic Therapeutics is a corporate sponsor for the Race For Hope taking place in Washington, DC on May 6, 2018 The Race for Hope-DC, a 5K course in the nation's ...
Bio+Tech18 reflects the changing landscape where life science and technology converge by bringing together professionals in both fields so that they may meet and forge new partnerships that will lead ...
The 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) scheduled to take place Nov. 7-11, 2018 at the Walter E. Washington Convention Center in ...
BIO is back in Boston to Celebrate 25 Years of Innovation The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, ...
This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Inova, Children’s National Health System, QIAGEN, Maryland Tech Council, University System of Maryland ...
AACR Annual Meeting 2018 Driving Innovative Cancer Science to Patient Care April 14-18, 2018 McCormick Place North/South Chicago, Illinois http://2018-aacr.org/
Research, Development And Strategic Partnering For The Global Vaccine Industry 2-5 April 2018, Renaissance Washington DC Downtown Hotel http://www.terrapinn.com/Conference/world-vaccine-congress-washington/index.stm
Scientific American custom media and Immunomic Therapeutics released an article titled, “The Fight Against Cancer is Increasingly Personal,” by reclassifying tumors, scientists are finding a path to genuine cancer cures. ...
Immunomic to Participate at 2018 BIO CEO & Investor Conference with Presentation and Panel Discussion
Immuno-Oncology Panel led by Scientific American February 12, 2018 07:30 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics (ITI), pioneering the study of investigational LAMP-based nucleic acid immunotherapy programs, ...
ITI Senior Director of Corporate Development to Present on LAMP-Vax Investigational Technology at Immuno-Oncology Frontiers World
January 23, 2018 11:24 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Tomorrow, Immunomic Therapeutics, Inc. Senior Director of Corporate Development Sia Anagnostou will present at Phacilitate’s Immuno-Oncology Frontiers World in Miami. ...
